Search results for "cumulative"

showing 10 items of 299 documents

Assessing sediment connectivity in dendritic and parallel calanchi systems

2019

Abstract Calanchi, a type of Italian badlands created by a combination of water erosion processes and environmental constraints controlling their development, is a striking example of long-term landscape evolution. Sediment connectivity can be defined as the degree to which a system facilitates the fluxes of sediments through itself. The goal of this research is testing the use of simple morphometric variables for assessing sediment connectivity of calanchi landforms distinguishing between dendritic and parallel systems. For detecting the morphological characteristics controlling the sediment connectivity of calanchi basins, literature data (146 calanchi basins) and measurements carried out…

Calanchigeographygeography.geographical_feature_category010504 meteorology & atmospheric sciencesLandformDrainage basinSedimentHack's law04 agricultural and veterinary sciencesStructural basinMelton's law01 natural sciencesSystem aCumulative frequency distribution040103 agronomy & agricultureSettore AGR/08 - Idraulica Agraria E Sistemazioni Idraulico-Forestali0401 agriculture forestry and fisheriesSediment transportBasin scaleGeomorphologyGeologySediment connectivity0105 earth and related environmental sciencesEarth-Surface ProcessesCATENA
researchProduct

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead

2015

Goodson, William H. et al.

Cancer ResearchCarcinogenesis[SDV]Life Sciences [q-bio]METHOXYCHLOR-INDUCED ALTERATIONSReviewPharmacologyMESH: Carcinogens EnvironmentalCarcinogenic synergiesChemical mixturesNeoplasmsMESH: AnimalsMESH: NeoplasmsCarcinogenesiRisk assessmentCancerACTIVATED PROTEIN-KINASESMedicine (all)Low dose1. No povertyCumulative effectsBREAST-CANCER CELLSGeneral MedicineEnvironmental exposureMESH: CarcinogenesisBIO/10 - BIOCHIMICAEPITHELIAL-MESENCHYMAL TRANSITION3. Good health[SDV] Life Sciences [q-bio]Environmental CarcinogenesisESTROGEN-RECEPTOR-ALPHARisk assessmentHumanMESH: Environmental ExposureENDOCRINE-DISRUPTING CHEMICALSTARGETING TISSUE FACTOR[SDV.CAN]Life Sciences [q-bio]/CancerBiologyPrototypical chemical disruptorsExposure[SDV.CAN] Life Sciences [q-bio]/CancerEnvironmental healthmedicine[SDV.EE.SANT] Life Sciences [q-bio]/Ecology environment/HealthCarcinogenEnvironmental carcinogenesis[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthMESH: HumansAnimalPOLYBROMINATED DIPHENYL ETHERSCancerEnvironmental Exposuremedicine.diseaseMESH: Hazardous SubstancesCarcinogens EnvironmentalMIGRATION INHIBITORY FACTORVASCULAR ENDOTHELIAL-CELLSHazardous SubstanceNeoplasmCarcinogenesis
researchProduct

Influence of Mitoxantrone on the Syntheses of Dna and Proteins of Mouse Tissues

1991

In view of the structural similarity of mitoxantrone to anthracyclines and its ability to intercalate into DNA, we studied its influence on the synthetic processes of DNA and proteins in CD-1 mice tissues. By studying at the DNA level the impairment of 2H-thymidine incorporation and its return to normal, it was found that bone marrow and spleen showed similar behavior, i.e., a rapid return to normal, which occurred before bone marrow cell number and spleen weight returned to basal values. At the cardiac level, the incorporation values of precursors into DNA, reduced by treatment with mitoxantrone, came back very slowly to the control ones. Hepatic DNA showed a lower sensitivity to mitoxant…

Cancer ResearchStructural similarityMuscle ProteinsSpleen030218 nuclear medicine & medical imagingMice03 medical and health sciencesBasal (phylogenetics)chemistry.chemical_compound0302 clinical medicineBone MarrowmedicineAnimalsDoxorubicinMitoxantroneCumulative doseChemistryMyocardiumHeartDNAGeneral MedicineMolecular biologymedicine.anatomical_structureLiverOncology030220 oncology & carcinogenesisBone marrowMitoxantroneSpleenDNAmedicine.drugTumori Journal
researchProduct

Abstract PD1-02: A phase I/Ib study evaluating GDC-0077 + palbociclib (palbo) + fulvestrant in patients (pts) with PIK3CA-mutant (mut), hormone recep…

2021

Abstract Background GDC-0077 is a PI3Kα-selective inhibitor and mutant PI3Kα degrader that demonstrates antitumor activity in PIK3CAmut BC xenograft models. A phase I/Ib study of GDC-0077 alone and combined with endocrine therapy ± the CDK4/6 inhibitor (i) palbo is ongoing (NCT03006172). Data from GDC-0077 + palbo + fulvestrant in pts with PIK3CAmut, HR+/HER2- mBC are presented herein. Methods Safety (NCI-CTCAE v4), pharmacokinetics (PK), and preliminary antitumor activity (clinical benefit rate [CBR]: RECIST v1.1 stable disease for ≥ 24 weeks, partial response [PR], or complete response) of 9 mg oral once daily GDC-0077 + 125 mg palbo 21/28 days + 500 mg intramuscular fulvestrant on day 1 …

Cancer Researchmedicine.medical_specialtyChemotherapyFulvestrantNauseaCumulative dosebusiness.industrymedicine.medical_treatmentNeutropeniaPalbociclibmedicine.diseaseGastroenterologyMetastatic breast cancerBreast cancerOncologyInternal medicinemedicinemedicine.symptombusinessmedicine.drugCancer Research
researchProduct

Abstract CT109: A phase I/Ib study evaluating GDC-0077 plus fulvestrant in patients with PIK3CA-mutant, hormone receptor-positive/HER2-negative breas…

2020

Abstract Background: PIK3CA encodes the PI3K p110α subunit, and dysregulating mutations are widely seen in breast cancer (BC) and other solid tumors. GDC-0077 (G) is a potent p110α-selective inhibitor that degrades mutant p110α and demonstrates antitumor activity in PIK3CA-mutant BC xenograft models, either as a single agent, or combined with anti-estrogen therapy. From an ongoing, open-label, phase I/Ib dose-escalation study of G alone and combined with endocrine + targeted therapies (NCT03006172), we present data of G + fulvestrant (F) in postmenopausal patients (pts) with PIK3CA-mutant, hormone receptor-positive/HER2-negative BC, including a food-effect assessment on the pharmacokinetics…

Cancer Researchmedicine.medical_specialtyFulvestrantbusiness.industryCumulative doseCmaxCancermedicine.diseaseGastroenterologyDysgeusiaBreast cancerOncologyPharmacokineticsPharmacodynamicsInternal medicinemedicinemedicine.symptombusinessmedicine.drugCancer Research
researchProduct

Abstract PS11-11: Targeted safety events from a phase I/Ib study evaluating GDC-0077 alone and in combination with endocrine therapy (ET) ± palbocicl…

2021

Abstract Background Activating mutations in PIK3CA, encoding the p110α subunit of phosphatidylinositol 3-kinase (PI3K) occur in ~40% of HR+/HER2- BCs. GDC-0077, a PI3Kα-selective inhibitor and mutant PI3Kα degrader, is being developed as an anticancer agent. A phase I/Ib study of GDC-0077 alone and combined with other therapies is ongoing in pts with locally advanced or metastatic PIK3CAmut, HR+/HER2- mBC (NCT03006172). Targeted safety events are presented here. Methods Safety was assessed via NCI-CTCAE v4 for GDC-0077 administered alone (Arm A), with letrozole and palbo (Arm B), with letrozole (Arm C), with fulvestrant (Arm D), or with fulvestrant and palbo (Arm E, plus metformin in Arm F …

Cancer Researchmedicine.medical_specialtyFulvestrantbusiness.industryCumulative doseLetrozolePalbociclibNeutropeniamedicine.diseaseRashMetastatic breast cancerGastroenterologyOncologyInternal medicineMaculopapular rashmedicinemedicine.symptombusinessmedicine.drugCancer Research
researchProduct

Chronic cumulative risk assessment of the exposure to organophosphorus, carbamate and pyrethroid and pyrethrin pesticides through fruit and vegetable…

2015

In the present study, the chronic cumulative exposure to organophosphorus (OPs), carbamates (CBs) and pyrethroid and pyrethrin (PPs) pesticides in the region of Valencia through fruit and vegetables consumption is presented. A total of 752 samples and 84 pesticides were studied of which, 52 were OPs, 23 CBs and 9 PPs. Residue data were derived from the Valencia Region monitoring program 2007-2011 and food consumption levels from a questionnaire-based dietary survey conducted in 2010 in the same area. The relative potency factor (RPFs) approach was used to estimate chronic cumulative dietary exposure to OPs, CBs and PPs using acephate, oxamyl and deltamethrin as index compounds, respectively…

Carbamatemedicine.medical_treatmentCumulative Exposure010501 environmental sciencesBiologyToxicology01 natural sciencesRisk AssessmentToxicologychemistry.chemical_compound0404 agricultural biotechnologyPyrethrinVegetablesmedicineHumansAcephate0105 earth and related environmental sciencesPyrethroidPesticide ResiduesUncertainty04 agricultural and veterinary sciencesGeneral MedicineEnvironmental ExposurePesticide040401 food scienceMonitoring programDeltamethrinchemistrySpainFruitFood ScienceFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association
researchProduct

Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients

2014

Background and PurposezzThe aim of this study was to elucidate the role of therapy-related cardiotoxicity in multiple sclerosis (MS) patients treated with mitoxantrone and to identify potential predictors for individual risk assessment. MethodszzWithin a multicenter retrospective cohort design, cardiac side effects attributed to mitoxantrone were analyzed in 639 MS patients at 2 MS centers in Germany. Demographic, disease, treatment, and follow-up data were collected from hospital records. Patients regularly received cardiac monitoring during the treatment phase. ResultszzNone of the patients developed symptomatic congestive heart failure. However, the frequency of patients experiencing car…

Cardiac function curvemedicine.medical_specialtyCardiotoxicityMitoxantronedose dependencybusiness.industryCumulative doseMultiple sclerosiscardiotoxicityRetrospective cohort studymultiple sclerosismedicine.diseasemitoxantroneNeurologyInternal medicineCohortmedicineOriginal ArticleNeurology (clinical)Risk factorbusinessIntensive care medicineFunction and Dysfunction of the Nervous Systemmedicine.drug
researchProduct

Oxygen Transport in Tumors

1996

Experimental evidence suggests that the hypoxic fraction in solid tumors may influence its growth, may increase its malignant potential, and may reduce its sensitivity towards non-surgical treatment modalities (e.g., standard irradiation, certain anticancer drugs). The role of the tumor O2 status in radio-/chemotherapy and its impact on relevant tumor biological characteristics of tumors are summarized in Table 1.

Cervical cancerChemotherapyNormal oral mucosaTreatment modalitybusiness.industrymedicine.medical_treatmentCancer researchmedicineOxygen transportbusinessmedicine.diseaseCumulative frequency distribution
researchProduct

On the statistical properties of the capacity of OSTBC Nakagami-lognormal MIMO channels

2010

This article presents a thorough statistical analysis of the capacity of orthogonal space-time block coded (OSTBC) Nakagami-lognormal (NLN) multiple-input multipleoutput (MIMO) channels. The NLN channel model allows to study the joint effects of fast fading and shadowing on the statistical properties of the channel capacity. We have derived exact analytical expressions for the probability density function (PDF), cumulative distribution function (CDF), level-crossing rate (LCR), and average duration of fades (ADF) of the capacity of NLN MIMO channels. It is observed that an increase in the MIMO dimension1 or a decrease in the severity of fading results in an increase in the mean channel capa…

Channel capacityCumulative distribution functionMIMOLog-normal distributionStatisticsFadingNakagami distributionProbability density functionStandard deviationComputer Science::Information TheoryMathematics2010 4th International Conference on Signal Processing and Communication Systems
researchProduct